2020

1. Assessing the impact on intestinal microbiome and clinical outcomes of antibiotherapy optimisation strategies in haematopoietic stem cell transplant recipients: Study protocol for the prospective multicentre OptimBioma study

   BMJ Open, Vol. 10, Núm. 7

2. Extended-spectrum resistance to β-lactams/β-lactamase inhibitors (ESRI) evolved from low-level resistant Escherichia coli

   Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 1, pp. 77-85